Medical devices, healthcare technology and the business of care
PMA SUPPLEMENT · P980023/S152

Ilivia Neo 7 VR-T DX DF-1 ProMRI, Ilivia Neo 7 VR-T DF-1 ProMRI, Intica Neo 7 VR-T DX DF-1 ProMRI, Intica Neo 7 VR-T DF-

Biotronik, Inc. · Decision date Oct 13, 2026

MEDTECHLEDGER EXPLANATIONP980023/S152

What did the FDA decide?

The FDA recorded decision OK30 on 2026-10-13 for PMA supplement P980023/S152, submitted by Biotronik, Inc. as a 30-Day Notice. The supplement reason is listed as a process change affecting a manufacturer, sterilizer, packager or supplier. The recorded statement describes a change to the rework process for manufacturing the housing of pulse generators and ICDs. The supplement attaches to P980023 rather than constituting a new approval of the underlying system.

The listed product line covers Ilivia Neo 7 VR-T DX DF-1 ProMRI, Ilivia Neo 7 VR-T DF-1 ProMRI, Intica Neo 7 VR-T DX DF-1 ProMRI and a fourth Intica Neo 7 VR-T entry whose title is truncated in the source. The device category is implantable cardioverter defibrillator (non-CRT), specialty cardiovascular, product code LWS. The source does not include the supplement documents, so the specific rework steps, affected housing lots and any FDA review detail remain unknown.

The OK30 designation and its practical effect on manufacturing are not explained in the available fields, and no clinical or performance data accompany this record. Readers should not infer changes to device labeling, indications or patient management from this process notice.

FDA approval order statement

a change to the rework process for the manufacturing of the housing for pulse generators and ICDS
Regulatory pathway
PMA supplement
Supplement type
30-Day Notice
Clinical specialty
Cardiovascular
Decision date
Oct 13, 2026
FDA change category
Process Change - Manufacturer/Sterilizer/Packager/Supplier

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P980023/S152
Regulatory pathway
PMA supplement
Product code
LWS
Decision code
OK30
Decision date
Oct 13, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Implantable cardioverter defibrillator (non-CRT).

Product code
LWS
FDA device class
3

For the original device and its historical approval scope, see PMA P980023. Subsequent supplements may change the device or its indications.

FDA decision timeline

  1. P980023 · Original PMA

    PHYLAX IMPLANTABLE CARDIOVERTER DEFIBRILLATOR SYSTEM

  2. P980023/S150 · Related supplement

    Pamira S 60; Pamira S 65; Pamira S 75; Pamira SD 60/16; Pamira SD 65/16; Pamira SD 65/18; Pamira SD 75/18; Pamira S DX 6

  3. P980023/S146 · Related supplement

    Acticor Sky VR-T, Rivacor Sky VR-T, Rivacor Rise VR-T, Rivacor Aura VR-T, Acticor Sky VR-T DX, Rivacor Sky VR-T DX, Riva

  4. P980023/S152 received

    Application receipt date recorded by FDA.

  5. P980023/S140 · Related supplement

    Ilivia Neo 7 VR-T DX 429530; Intica Neo 7 VR-T DX 429559; Intica Neo 5 VR-T DX 429569

  6. P980023/S151 · Related supplement

    Acticor Sky VR-T, Rivacor Sky VR-T, Rivacor Rise VR-T, Rivacor Aura VR-T, Acticor Sky VR-T DX, Rivacor Sky VR-T DX, Riva

  7. P980023/S149 · Related supplement

    Acticor Sky VR-T 481989; Rivacor Sky VR-T 481984; Rivacor Rise VR-T 482020; Rivacor Aura VR-T 482015; Acticor Sky VR-T D

  8. P980023/S152 · FDA decision

    30-Day Notice

  9. P980023/S153 · Related supplement

    Ilivia Neo 7 VRT DX, Intica Neo 7 VRT DX, Intica Neo 5 VRT DX, Acticor Sky VR-T, Rivacor Sky VR-T, Rivacor Rise VR-T, Ri

Timeline entries are records held by MedtechLedger for P980023. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P980023

Explore the linked device profile

Other records with product code LWS

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Biotronik, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
6024 Jean Rd., Lake Oswego, OR, 97035

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records